1 . This hallmark EMT signature fully comprised Mes genes, with only 2 genes (LAMC2, VIM) that overlapped with the EMT signature we derived.
Consistent with our finding of 4 out of 223 (1%) Mes genes that harbored EMT− DMC at TSS, only 6 out of 168 Mes genes (3.5%) in this gene set contained EMT− DMC at TSS (Supplementary Data 4) . 21 out of 170 Mes genes had intragenic EMT+ DMCs whereas 4 out of 170 Mes genes contained intragenic EMT− DMCs. On the other hand, no hallmark gene set was available for epithelial genes. Hence, we selected the genes listed in Gene Ontology 2 epithelial differentiation gene set with gene expressions that significantly anti-correlate with EMT (p < 0.05). In this gene set, we found 20 over 45 Epi genes (44.4%) that harbored EMT+ DMCs at TSS, an observation similar to what we reported. 10 out of 46 Epi genes (21.7%) had EMT+ DMCs whereas 10 other Epi genes had EMT− DMCs in their gene bodies, respectively. In summary, using two different gene sets related to EMT, we obtained similar findings in OC cells, suggesting that Epi genes were more susceptible to DNA methylation-mediated regulation, as compared to Mes genes.
EMT-correlated DMCs in clinical tumor samples.
We tested if the observation of epithelial genes being more susceptible to DNA methylation could be reproduced in clinical samples of ovarian and other cancers. To this end, we checked whether the correlation between CpG methylation and EMT score (computed from gene expression) of clinical samples were concordant with that of ovarian cancer cell lines. To perform the analyses, we obtained the methylation profiles (Illumina Infinium 450K array data) of ovarian and other cancers of the TCGA cohorts 3 . Only 9 samples in the TCGA ovarian cancer cohort had both 450K and RNA-seq data. Hence, we included additional ovarian tumor samples of the Duke cohort (GSE51820) 4 for analyses alongside. The CpG sites analysed were selected based on two criteria-1: EMT-correlated DMCs identified in ovarian cancer cell lines, 2: located at TSS of the EMT signature genes. Interestingly, several cancer types such as the breast and bladder cancer (BLCA) showed consistent EMTmethylation correlation at CpG sites near TSS of epithelial genes but only marginal or no correlation in mesenchymal genes ( Supplementary Fig. 3 ). This suggested that our finding of epithelial genes being more susceptible to DNA methylation regulation could be applied not only to ovarian cancer cell lines but also to clinical samples of ovarian and other cancer types.
Worth noting, the sarcoma-like mesenchymal tumors such as GBM and SKCM showed no correlation at the selected CpG sites.
Supplementary Figures
Supplementary Fig. 1 Abbreviations: BLCA, bladder urothelial carcinoma; BRCA, breast invasive carcinoma; COADREAD, colorectal adenocarcinoma; GBM, glioblastoma; HNSC, head and neck squamous cell carcinoma; KIRC, kidney renal cell carcinoma; KIRP, kidney renal papillary cell carcinoma; LIHC, liver hepatocellular carcinoma; LUAD, lung adenocarcinoma; LUSC, lung squamous cell carcinoma; OV, ovarian serous cystadenocarcinoma; PAAD, pancreatic adenocarcinoma; PRAD, prostate adenocarcinoma; SKCM, skin cutaneous melanoma; STAD, stomach adenocarcinoma; UCEC, uterine corpus endometrial carcinoma. 
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